Targeting ULK1 could be an effective strategy for inhibiting autophagy in cancer progression because several inhibitors targeting the mid-term or late stages of autophagy could activate pro-survival kinases such as ULK1 during the initial autophagy process42. This evidence concerns the gene ULK1 and cancer.